FURADANTIN Side Effects

6963907-7 | Hypoacusis
on Aug 17, 2010 Female patient from ITALY , 38 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoacusis. Furadantin dosage: 50 Mg Daily, Oral. Patient was hospitalized.

6939579-4 | Hepatic Failure
Patient was taking Furadantin (View Usage). Patient had the following side effects: hepatic failure on Aug 09, 2010 from FRANCE Additional patient health information: Male patient , 79 years of age, . Furadantin dosage: 50mg Three Times A Day, Oral, 50 Mg Every Two Days. Patient was hospitalized.

6693651-5 | Dysuria, Eosinophilia, Inflammation, Left Ventricular Failure, Pyrexia
Adverse event was reported on Apr 07, 2010 by a Female patient taking Furadantin (View Usage) (Dosage: 50 Mg Three Times A Daily,oral) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 71 years of age, After Furadantin was administered, patient had the following side effects: dysuria, eosinophilia, inflammation, left ventricular failure, pyrexia. During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), MAGNE BE /00869191/ (MAGNESIUM LACTATE, PYRIDOXINE HYDROCHLORIDE) (View Magne Be /00869191/ (magnesium Lactate, Pyridoxine Hydrochloride) Review and Magne Be /00869191/ (magnesium Lactate, Pyridoxine Hydrochloride) Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6660450-X | International Normalised Ratio Increased, Multi-organ Failure, Septic Shock
on Mar 15, 2010 Female patient from FRANCE , 80 years of age, was diagnosed with pyelonephritis, septic shock and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, multi-organ failure, septic shock. Furadantin dosage: Oral. During the same period patient was treated with PREVISCAN /00789001/ (FLUINDIONE) (10 Mg Daily, Oral) (View Previscan /00789001/ (fluindione) Review and Previscan /00789001/ (fluindione) Label ), CIFLOX /00697201/ (CIPROFLOXACIN) (Intravesical) (View Ciflox /00697201/ (ciprofloxacin) Review and Ciflox /00697201/ (ciprofloxacin) Label ). Patient was hospitalized.


6574298-8 | Abortion Induced, Oligohydramnios
on Jan 21, 2010 Female patient from FRANCE , 30 years of age, was diagnosed with urinary tract infection pseudomonal and was treated with Furadantin (View Usage). Patient had the following side effects: abortion induced, oligohydramnios. Furadantin dosage: Oral. During the same period patient was treated with GENTALINE (GENTALINE SULFATE) (80 Mg, Daily) (View Gentaline (gentaline Sulfate) Review and Gentaline (gentaline Sulfate) Label ), HOMEOPATHIC PREPARATION (COLIBACILLUM) (View Homeopathic Preparation (colibacillum) Review and Homeopathic Preparation (colibacillum) Label ), CRANBERRY (VACCINIUM MACROCARPON) (View Cranberry (vaccinium Macrocarpon) Review and Cranberry (vaccinium Macrocarpon) Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), PULSATILLA (PULSATILLA PRATENSIS) (View Pulsatilla (pulsatilla Pratensis) Review and Pulsatilla (pulsatilla Pratensis) Label ), PHOSPHORUS (PHOSPHORUS) (View Phosphorus (phosphorus) Review and Phosphorus (phosphorus) Label ), OPIUM DERIVATIVES AND EXPECTORANTS (View Opium Derivatives And Expectorants Review and Opium Derivatives And Expectorants Label ), HAMAMELIS (HAMAMELIS VIRGINIANA LIQUID EXTRACT) (View Hamamelis (hamamelis Virginiana Liquid Extract) Review and Hamamelis (hamamelis Virginiana Liquid Extract) Label ).

6537969-5 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Collapse Of Lung, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased, Leukocytosis, Lung Disorder, Pleural Effusion
Patient was taking Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, collapse of lung, gamma-glutamyltransferase increased, hepatic enzyme increased, leukocytosis, lung disorder, pleural effusion on Dec 29, 2009 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with bacterial test positive, antiviral prophylaxis and. Furadantin dosage: 50 Mg, Oral. During the same period patient was treated with MUTAGRIP /00027001/(INFLUENZA VIRUS VACCINE POLYVALENT) (1 Df, 1 Only) (View Mutagrip /00027001/(influenza Virus Vaccine Polyvalent) Review and Mutagrip /00027001/(influenza Virus Vaccine Polyvalent) Label ), TANAKAN /01003103/ (GINKGO BILOBA EXTRACT) (View Tanakan /01003103/ (ginkgo Biloba Extract) Review and Tanakan /01003103/ (ginkgo Biloba Extract) Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), BIPRETERAX (INDAPAMIDE, PERINDOPRIL ERBUMINE) (View Bipreterax (indapamide, Perindopril Erbumine) Review and Bipreterax (indapamide, Perindopril Erbumine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RHINOTROPHYL (ETHANOLAMINE TENOATE, FRAMYCETIN SULFATE) (View Rhinotrophyl (ethanolamine Tenoate, Framycetin Sulfate) Review and Rhinotrophyl (ethanolamine Tenoate, Framycetin Sulfate) Label ). Patient was hospitalized.

6518038-7 | Agitation, Aphasia, Cerebral Haematoma, Constipation, Dyspnoea, International Normalised Ratio Increased, Loss Of Consciousness
Adverse event was reported on Dec 07, 2009 by a Female patient taking Furadantin (View Usage) (Dosage: 50 Mg, Oral) was diagnosed with urinary tract infection (What is urinary tract infection?), thrombosis prophylaxis and. Location: FRANCE , 86 years of age, Patient experienced the following unwanted or unexpected effects: agitation, aphasia (What is aphasia?), cerebral haematoma, constipation (What is constipation?), dyspnoea, international normalised ratio increased, loss of consciousness. During the same period patient was treated with PREVISCAN (FLUINDIONE) TABLET, 20MG (According To Inr, Oral) (View Previscan (fluindione) Tablet, 20mg Review and Previscan (fluindione) Tablet, 20mg Label ), EFFEXOR /01233801/ (VENLAFAXINE) (View Effexor /01233801/ (venlafaxine) Review and Effexor /01233801/ (venlafaxine) Label ), MONOCRIXO (TRAMADOL HYDROCHLORIDE) (View Monocrixo (tramadol Hydrochloride) Review and Monocrixo (tramadol Hydrochloride) Label ), COVERSYL /0079701/ (PERINDOPRIL) (View Coversyl /0079701/ (perindopril) Review and Coversyl /0079701/ (perindopril) Label ), ATARAX (View Atarax Review and Atarax Label ), TETRAZEPAM (TETRAZEPAM) (View Tetrazepam (tetrazepam) Review and Tetrazepam (tetrazepam) Label ). Patient was hospitalized.

6408673-9 | Confusional State, Dialysis, Eosinophilia, Incorrect Dose Administered, Interstitial Lung Disease, Leukocyturia, Renal Failure Acute, Tubulointerstitial Nephritis
on Oct 05, 2009 Female patient from FRANCE , 85 years of age, was treated with Furadantin (View Usage). Patient had the following side effects: confusional state, dialysis (What is dialysis?), eosinophilia, incorrect dose administered, interstitial lung disease, leukocyturia, renal failure acute, tubulointerstitial nephritis. Furadantin dosage: 100 Mg Daily, Oral. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), FOSAVANCE (ALENDRONATE SODIUM, COLECALCIFEROL) (View Fosavance (alendronate Sodium, Colecalciferol) Review and Fosavance (alendronate Sodium, Colecalciferol) Label ). Patient was hospitalized.

6380318-6 | Anxiety, Tenderness
on Sep 08, 2009 Female patient from FRANCE , 77 years of age, was diagnosed with cystitis and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: anxiety (What is anxiety?), tenderness. Furadantin dosage: 50 Mg 4 Times Daily, Oral. Patient was hospitalized.

6371309-X | Anxiety, Tenderness
Patient was taking Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), tenderness on Sep 08, 2009 from FRANCE Additional patient health information: Female patient , 77 years of age, was diagnosed with cystitis and. Furadantin dosage: 50 Mg 4 Times Daily, Oral. Patient was hospitalized.

6196927-3 | Coordination Abnormal, Gait Disturbance, Paraesthesia, Paraesthesia Oral, Sensory Loss
Adverse event was reported on May 05, 2009 by a Female patient taking Furadantin (View Usage) (Dosage: 6 Dosage Forms Daily, Oral) was diagnosed with cystitis and. Location: FRANCE , 80 years of age, Patient had the following side effects: coordination abnormal, gait disturbance, paraesthesia, paraesthesia oral, sensory loss. During the same period patient was treated with TANAKAN (GINKGO BILOBA EXTRACT) (View Tanakan (ginkgo Biloba Extract) Review and Tanakan (ginkgo Biloba Extract) Label ).

6076587-2 | Abdominal Pain, Candidiasis, Clostridium Difficile Colitis, Fungus Stool Identified, Pyrexia, Systemic Inflammatory Response Syndrome
on Jan 28, 2009 Female patient from FRANCE , 82 years of age, was diagnosed with bacterial infection (What is bacterial infection?) and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), candidiasis, clostridium difficile colitis, fungus stool identified, pyrexia, systemic inflammatory response syndrome. Furadantin dosage: Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COKENZEN (CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE) (View Cokenzen (candesartan Cilexetil, Hydrochlorothiazide) Review and Cokenzen (candesartan Cilexetil, Hydrochlorothiazide) Label ). Patient was hospitalized.

6052223-6 | Epistaxis
on Dec 19, 2008 Female patient from FRANCE , child 6 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis. Furadantin dosage: Oral. During the same period patient was treated with DITROPAN (View Ditropan Review and Ditropan Label ).

6024084-2 | Hypersensitivity, Renal Failure Acute, Tubulointerstitial Nephritis
Patient was taking Furadantin (View Usage). Patient had the following side effects: hypersensitivity, renal failure acute, tubulointerstitial nephritis on Dec 11, 2008 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with cystitis, hypertension and. Furadantin dosage: Oral. During the same period patient was treated with LODOZ /01166101/ (BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE) 10/6.25MG (Oral) (View Lodoz /01166101/ (bisoprolol Fumarate, Hydrochlorothiazide) 10/6.25mg Review and Lodoz /01166101/ (bisoprolol Fumarate, Hydrochlorothiazide) 10/6.25mg Label ), AROMASIN (View Aromasin Review and Aromasin Label ). Patient was hospitalized.

6015495-X | Atelectasis, Cough, Inflammation, Pleural Disorder, Purpura, Pyrexia
Adverse event was reported on Dec 04, 2008 by a Female patient taking Furadantin (View Usage) (Dosage: 150 Mg Daily, Oral) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 71 years of age, After Furadantin was administered, patient had the following side effects: atelectasis, cough, inflammation, pleural disorder (What is pleural disorder?), purpura, pyrexia. Patient was hospitalized.

5941084-9 | Arthralgia, Body Temperature Increased, Bone Pain, Condition Aggravated, Dyspnoea, Erythema, Haematuria, Musculoskeletal Chest Pain
on Oct 16, 2008 Female patient from FRANCE , 68 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, body temperature increased, bone pain, condition aggravated, dyspnoea, erythema, haematuria, musculoskeletal chest pain. Furadantin dosage: 50 Mg Three Times Daily, Oral. During the same period patient was treated with CLAMOXYL /00249601/ (AMOXICILLIN) (View Clamoxyl /00249601/ (amoxicillin) Review and Clamoxyl /00249601/ (amoxicillin) Label ). Patient was hospitalized.

5926102-6 | Abdominal Pain, Anaemia, Anorexia, Blood Glucose Increased, Blood Sodium Decreased, Blood Urea Increased, Cardiac Murmur, Convulsion
on Oct 01, 2008 Female patient from FRANCE , 91 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), atrial fibrillation (What is atrial fibrillation?) and was treated with Furadantin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, anorexia, blood glucose increased, blood sodium decreased, blood urea increased, cardiac murmur, convulsion. Furadantin dosage: 1 Dosage Form 3 Times Daily, Oral. During the same period patient was treated with PREVISCAN (FLUINDIONE) TABLET, 20MG (0.25 Dosage Form Daily, Oral; 0.25 Df Every 4 Days, Oral) (View Previscan (fluindione) Tablet, 20mg Review and Previscan (fluindione) Tablet, 20mg Label ), DIGOXINE NATIVELLE (DIGOXIN) 25 MG (View Digoxine Nativelle (digoxin) 25 Mg Review and Digoxine Nativelle (digoxin) 25 Mg Label ), CORDARONE /00133101/ (AMIODARONE) (View Cordarone /00133101/ (amiodarone) Review and Cordarone /00133101/ (amiodarone) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), EFFERALGAN /00020001/ (PARACETAMOL) (View Efferalgan /00020001/ (paracetamol) Review and Efferalgan /00020001/ (paracetamol) Label ), TRIATEC /00116401/ (CODEINE PHOSPHATE, PARACETAMOL) (View Triatec /00116401/ (codeine Phosphate, Paracetamol) Review and Triatec /00116401/ (codeine Phosphate, Paracetamol) Label ), ISKEDYL (DIHYDROERGOCRISTINE MESILATE, RAUBASINE) (View Iskedyl (dihydroergocristine Mesilate, Raubasine) Review and Iskedyl (dihydroergocristine Mesilate, Raubasine) Label ). Patient was hospitalized.

5917576-5 | Chest Discomfort, Chest Pain, Oropharyngeal Pain, Pain In Extremity, Pyrexia
Patient was taking Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?), oropharyngeal pain, pain in extremity, pyrexia on Sep 26, 2008 from FRANCE Additional patient health information: Male patient , 60 years of age, weighting 180.8 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Furadantin dosage: 2 Dose Forms Daily, Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), COAPROVEL 150/12.5 (HYDROCHLOROTHIAZIDE, IRBESARTAN) (View Coaprovel 150/12.5 (hydrochlorothiazide, Irbesartan) Review and Coaprovel 150/12.5 (hydrochlorothiazide, Irbesartan) Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

5890692-2 | Chest Discomfort, Chest Pain, Pyrexia
Adverse event was reported on Sep 04, 2008 by a Male patient taking Furadantin (View Usage) (Dosage: Oral) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: chest discomfort, chest pain (What is chest pain?), pyrexia. During the same period patient was treated with METFORMIN (METFORMIN) TABLET (View Metformin (metformin) Tablet Review and Metformin (metformin) Tablet Label ), COAPROVEL 150/12.5 (HYDROCHLOROTHIAZIDE, IRBESARTAN) TABLET (View Coaprovel 150/12.5 (hydrochlorothiazide, Irbesartan) Tablet Review and Coaprovel 150/12.5 (hydrochlorothiazide, Irbesartan) Tablet Label ). Patient was hospitalized.

5822573-4 | Haematuria
on Jul 07, 2008 Male patient from FRANCE , 77 years of age, was diagnosed with bacteria urine identified and was treated with Furadantin (View Usage). Patient had the following side effects: haematuria. Furadantin dosage: 1 Dosage Form Daily For 2 Days, Oral. During the same period patient was treated with PREVISCAN(FLUINDIONE) TABLET, 20MG (Oral) (View Previscan(fluindione) Tablet, 20mg Review and Previscan(fluindione) Tablet, 20mg Label ), PROSCAR (View Proscar Review and Proscar Label ), URISPAS (View Urispas Review and Urispas Label ), ALDACTAZINE (SPIRONOLACTONE, ALTIZIDE) (View Aldactazine (spironolactone, Altizide) Review and Aldactazine (spironolactone, Altizide) Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

5788862-7 | Haemolytic Anaemia, Petechiae, Thrombocytopenia
on Jun 06, 2008 Female patient from AUSTRALIA , 32 years of age, was diagnosed with urinary tract disorder and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: haemolytic anaemia, petechiae, thrombocytopenia. Furadantin dosage: 300 Mg Daily, Oral. During the same period patient was treated with ORAL CONTRACEPTIVE NOS (ORAL CONTRACEPTIVE NOS) (View Oral Contraceptive Nos (oral Contraceptive Nos) Review and Oral Contraceptive Nos (oral Contraceptive Nos) Label ). Patient was hospitalized.

5574085-3 | Pancreatitis Acute
Patient was taking Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Dec 10, 2007 from FRANCE Additional patient health information: Female patient , 84 years of age, . Furadantin dosage: 3 Df Daily, Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (25 Ug Daily, Oral) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOPICLONE(ZOPICLONE) (7.5 Mg Daily, Oral) (View Zopiclone(zopiclone) Review and Zopiclone(zopiclone) Label ), PLAVIX (1 Df Daily, Oral) (View Plavix Review and Plavix Label ), EQUANIL (3 Df Daily, Rectal) (View Equanil Review and Equanil Label ). Patient was hospitalized.

5552121-8 | Blood Immunoglobulin A Increased, Blood Immunoglobulin E Increased, Blood Immunoglobulin G Increased, Blood Immunoglobulin M Increased, Leukocytoclastic Vasculitis
Adverse event was reported on Nov 26, 2007 by a Female patient taking Furadantin (View Usage) (Dosage: Oral) . Location: FRANCE , 81 years of age, Patient had the following side effects: blood immunoglobulin a increased, blood immunoglobulin e increased, blood immunoglobulin g increased, blood immunoglobulin m increased, leukocytoclastic vasculitis. During the same period patient was treated with INEXIUM /01479302/(ESOMEPRAZOLE MAGNESIUM) (Oral) (View Inexium /01479302/(esomeprazole Magnesium) Review and Inexium /01479302/(esomeprazole Magnesium) Label ), TOPAAL(SILICA GEL, MAGNESIUM CARBONATE, ALUMINIUM HYDROXIDE GEL, ALGIN (Oral) (View Topaal(silica Gel, Magnesium Carbonate, Aluminium Hydroxide Gel, Algin Review and Topaal(silica Gel, Magnesium Carbonate, Aluminium Hydroxide Gel, Algin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ). Patient was hospitalized.

5511230-X | Pancytopenia
on Oct 24, 2007 Female patient from FRANCE , 76 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), type 2 diabetes mellitus and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: pancytopenia. Furadantin dosage: 150 Mg, Daily, Oral. During the same period patient was treated with ACTONEL (35 Mg, Once Weekly, Oral) (View Actonel Review and Actonel Label ), DAONIL(GLIBENCLAMIDE) (5 Mg, 3 Day) (View Daonil(glibenclamide) Review and Daonil(glibenclamide) Label ), INEXIUM /01479302/(ESOMPERAZOLE MAGNESIUM) (20 Mg Daily, Oral) (View Inexium /01479302/(esomperazole Magnesium) Review and Inexium /01479302/(esomperazole Magnesium) Label ), TRIATEC /00116401/(PARACETAMOL, CODEINE PHOSPHATE) (7.5 Mg Daily) (View Triatec /00116401/(paracetamol, Codeine Phosphate) Review and Triatec /00116401/(paracetamol, Codeine Phosphate) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5429222-8 | Methaemoglobinaemia, Nephrolithiasis
on Aug 27, 2007 Female patient from UNITED STATES , 64 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, nephrolithiasis. Furadantin dosage: 100 Mg Bid Po.

5429212-5 | Cyanosis, Methaemoglobinaemia, Nephrolithiasis, Oxygen Saturation Decreased
Patient was taking Furadantin (View Usage). Patient had the following side effects: cyanosis, methaemoglobinaemia, nephrolithiasis, oxygen saturation decreased on Aug 27, 2007 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Furadantin dosage: 100 Mg Bid Po.

5371965-9 | Anaemia, Anger, Cardiac Failure, Cardiovascular Disorder, Jaundice, Neurological Symptom, Renal Failure Acute, Respiratory Failure
Adverse event was reported on Jun 13, 2007 by a Female patient taking Furadantin (View Usage) (Dosage: 100 Mg, Oral) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: ITALY , 88 years of age, After Furadantin was administered, patient had the following side effects: anaemia, anger, cardiac failure, cardiovascular disorder, jaundice (What is jaundice?), neurological symptom, renal failure acute, respiratory failure. During the same period patient was treated with SELEPARINA (HEPARIN FRACTION, CALCIUM SALT) SOLUTION (View Seleparina (heparin-fraction, Calcium Salt) Solution Review and Seleparina (heparin-fraction, Calcium Salt) Solution Label ), ENAPREN (ENALAPRIL MALEATE) TABLET (View Enapren (enalapril Maleate) Tablet Review and Enapren (enalapril Maleate) Tablet Label ), CALCIUM SANDOZ (CALCIUM GLUCONATE) (View Calcium Sandoz (calcium Gluconate) Review and Calcium Sandoz (calcium Gluconate) Label ), LASITONE (SPIRONOLACTONE, FUROSEMIDE) CAPSULE (View Lasitone (spironolactone, Furosemide) Capsule Review and Lasitone (spironolactone, Furosemide) Capsule Label ).

5357165-7 | Anger, Jaundice, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
on May 31, 2007 Female patient from ITALY , 88 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: anger, jaundice (What is jaundice?), renal failure acute, thrombotic thrombocytopenic purpura. Furadantin dosage: 100 Mg, Oral. During the same period patient was treated with SELEPARINA (HEPARIN FRACTION, CALCIUM SALT) (View Seleparina (heparin-fraction, Calcium Salt) Review and Seleparina (heparin-fraction, Calcium Salt) Label ), ENAPREN (ENALAPRIL MALEATE) (View Enapren (enalapril Maleate) Review and Enapren (enalapril Maleate) Label ), CALCIUM (CALCIUM GLUCONATE) (View Calcium (calcium Gluconate) Review and Calcium (calcium Gluconate) Label ), LASITONE (SPIRONOLACTONE, FUROSEMIDE) (View Lasitone (spironolactone, Furosemide) Review and Lasitone (spironolactone, Furosemide) Label ).

5339452-1 | Abdominal Pain, Anorexia, Colonic Polyp, Diarrhoea, Gamma-glutamyltransferase Increased, Nausea, Rectal Haemorrhage
on May 14, 2007 Female patient from FRANCE , 61 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anorexia, colonic polyp (What is colonic polyp?), diarrhoea, gamma-glutamyltransferase increased, nausea (What is nausea?), rectal haemorrhage. Furadantin dosage: Olne Dose Form Daily, Oral. During the same period patient was treated with VEINAMITOL(TROXERUTIN) (1000 Mg/m2 Ml, Twice Daily, Oral) (View Veinamitol(troxerutin) Review and Veinamitol(troxerutin) Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), GINKOR (TROXERUTIN, GINKGO BILOBA EXTRACT) (View Ginkor (troxerutin, Ginkgo Biloba Extract) Review and Ginkor (troxerutin, Ginkgo Biloba Extract) Label ). Patient was hospitalized.

5159322-1 | Parotitis
Patient was taking Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: parotitis on Nov 06, 2006 from FRANCE Additional patient health information: Female patient , 94 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Furadantin dosage: 2 Capsules Three Times Daily, Oral. Patient was hospitalized.

5145643-5 | Anaemia, Cholangitis Acute, Erythrosis, Hepatitis Cholestatic, Renal Failure, Urinary Retention, Urinary Tract Infection
Adverse event was reported on Oct 17, 2006 by a Male patient taking Furadantin (View Usage) (Dosage: Oral) was diagnosed with urinary tract infection (What is urinary tract infection?), arrhythmia (What is arrhythmia?), ischaemic cardiomyopathy and. Location: FRANCE , 82 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, cholangitis acute, erythrosis, hepatitis cholestatic, renal failure, urinary retention, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CORDARONE (200 Mg Once Daily, Oral) (View Cordarone Review and Cordarone Label ), PLAVIX (Oral) (View Plavix Review and Plavix Label ), FORLAX (MACROGOL) POWDER (View Forlax (macrogol) Powder Review and Forlax (macrogol) Powder Label ). Patient was hospitalized.

5129912-0 | Anaemia, Duodenal Ulcer Haemorrhage, International Normalised Ratio Increased
on Oct 04, 2006 Male patient from FRANCE , 92 years of age, was treated with Furadantin (View Usage). Patient had the following side effects: anaemia, duodenal ulcer haemorrhage, international normalised ratio increased. Furadantin dosage: 3 Df Daily, Oral. During the same period patient was treated with COUMADIN (2 Mg Once Daily, Oral) (View Coumadin Review and Coumadin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), EUPRESSYL (URAPIDIL) CAPSULE (View Eupressyl (urapidil) Capsule Review and Eupressyl (urapidil) Capsule Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), OMIX (TAMSULOSIN HYDROCHLORIDE) (View Omix (tamsulosin Hydrochloride) Review and Omix (tamsulosin Hydrochloride) Label ). Patient was hospitalized.

5023445-8 | Lichenoid Keratosis, Rash Papular, Rash Pruritic
on May 24, 2006 Female patient from FRANCE , 74 years of age, was diagnosed with antibiotic prophylaxis and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: lichenoid keratosis, rash papular, rash pruritic. Furadantin dosage: 2 Df Daily As Needed, Oral. During the same period patient was treated with PRESTOLE (TRIAMTERENE, HYDROCHLOROTHIAZIDE) (1 Df Daily, Oral) (View Prestole (triamterene, Hydrochlorothiazide) Review and Prestole (triamterene, Hydrochlorothiazide) Label ), KARDEGIC /FRA/(ACETYLSALICYLATE LYSINE) (View Kardegic /fra/(acetylsalicylate Lysine) Review and Kardegic /fra/(acetylsalicylate Lysine) Label ), HYPERIUM (RILMENIDINE) (View Hyperium (rilmenidine) Review and Hyperium (rilmenidine) Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), TRASICOR (OXPRENOLOL HYDROCHLORIDE) (View Trasicor (oxprenolol Hydrochloride) Review and Trasicor (oxprenolol Hydrochloride) Label ), TANAKAN (GINKGO BILOBA EXTRACT) (View Tanakan (ginkgo Biloba Extract) Review and Tanakan (ginkgo Biloba Extract) Label ), DIFRAREL (BETACAROTENE, VACCINIUM MYRTILLUS) (View Difrarel (betacarotene, Vaccinium Myrtillus) Review and Difrarel (betacarotene, Vaccinium Myrtillus) Label ), VASTAREL ^BIOPHARMA^ (TRIMETAZIDINE HYDROCHLORIDE) (View Vastarel ^biopharma^ (trimetazidine Hydrochloride) Review and Vastarel ^biopharma^ (trimetazidine Hydrochloride) Label ). Patient was hospitalized.

4996403-7 | Hypersensitivity, Pyelonephritis, Vomiting
Patient was taking Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, pyelonephritis, vomiting on Apr 26, 2006 from FRANCE Additional patient health information: Female patient , 46 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), renal colic and. Furadantin dosage: Oral. During the same period patient was treated with PROFENID ^AVENTIS PHARMA^ (KETOPROFEN) (Oral) (View Profenid ^aventis Pharma^ (ketoprofen) Review and Profenid ^aventis Pharma^ (ketoprofen) Label ), SPASFON (PHLOROGLUCINOL, TRIMETHYLPHLOROGLUCINOL) (Oral) (View Spasfon (phloroglucinol, Trimethylphloroglucinol) Review and Spasfon (phloroglucinol, Trimethylphloroglucinol) Label ). Patient was hospitalized.

4978394-8 | Cardiac Failure Acute, Infection, Interstitial Lung Disease
Adverse event was reported on Apr 05, 2006 by a Female patient taking Furadantin (View Usage) (Dosage: Oral) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 93 years of age, Patient had the following side effects: cardiac failure acute, infection (What is infection?), interstitial lung disease. During the same period patient was treated with PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), CORDARONE (View Cordarone Review and Cordarone Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

4959744-5 | Cholangitis, Hepatitis Cholestatic
on Mar 14, 2006 Female patient from FRANCE , 75 years of age, was diagnosed with cystitis and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: cholangitis, hepatitis cholestatic. Furadantin dosage: 1 Df Daily, Oral. During the same period patient was treated with VALSARTAN (160 Mg Daily, Oral) (View Valsartan Review and Valsartan Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

4939384-4 | Lower Gastrointestinal Haemorrhage, Rectal Haemorrhage
on Feb 22, 2006 Female patient from FRANCE , 83 years of age, was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: lower gastrointestinal haemorrhage, rectal haemorrhage. Furadantin dosage: 1 Df Daily, Oral. During the same period patient was treated with FUROSEMIDE (20 Mg, Daily, Oral) (View Furosemide Review and Furosemide Label ), ASPIRIN (160 Mg Daily, Oral) (View Aspirin Review and Aspirin Label ), FENOFIBRATE (1 Df Daily, Oral) (View Fenofibrate Review and Fenofibrate Label ), CELECTOL (View Celectol Review and Celectol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), LEXOMIL (BROMAZEPAM) (View Lexomil (bromazepam) Review and Lexomil (bromazepam) Label ). Patient was hospitalized.

4939200-0 | Hepatitis Acute, Hypochromic Anaemia, Tremor
Patient was taking Furadantin (View Usage). Patient had the following side effects: hepatitis acute, hypochromic anaemia, tremor on Feb 20, 2006 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with cystitis and. Furadantin dosage: See Image. During the same period patient was treated with TENORMIN (50 Mg Daily) (View Tenormin Review and Tenormin Label ), ACETAMINOPHEN (3 G Daily, Oral) (View Acetaminophen Review and Acetaminophen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SERMION (NICERGOLINE) (View Sermion (nicergoline) Review and Sermion (nicergoline) Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ADANCOR (NICORANDIL) (View Adancor (nicorandil) Review and Adancor (nicorandil) Label ). Patient was hospitalized.

4924659-5 | Hepatitis Acute, Hypochromic Anaemia
Adverse event was reported on Feb 08, 2006 by a Female patient taking Furadantin (View Usage) (Dosage: 300 Mg Daily, Oral; See Image) was diagnosed with cystitis and. Location: FRANCE , 81 years of age, After Furadantin was administered, patient had the following side effects: hepatitis acute, hypochromic anaemia. During the same period patient was treated with ADANCOR (NICORANDIL) (View Adancor (nicorandil) Review and Adancor (nicorandil) Label ), TENORMIN (View Tenormin Review and Tenormin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KARDEGIC /FRA/ (ACETYLSALICYLATE LYSINE) (View Kardegic /fra/ (acetylsalicylate Lysine) Review and Kardegic /fra/ (acetylsalicylate Lysine) Label ), SERMION (NICERGOLINE) (View Sermion (nicergoline) Review and Sermion (nicergoline) Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), TEMESTA (LORAZEPAM) (View Temesta (lorazepam) Review and Temesta (lorazepam) Label ). Patient was hospitalized.

4864200-9 | Condition Aggravated, Diarrhoea, Renal Failure
on Dec 05, 2005 Female patient from FRANCE , child 10 years of age, was diagnosed with cystitis and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, diarrhoea, renal failure. Furadantin dosage: 1 Df Three Times Daily, Oral. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), VAGOSTABYL (CALCIUM LACTATE, CRATAEGUS LAEVIGATA, MELISSA OFFICINALIS (View Vagostabyl (calcium Lactate, Crataegus Laevigata, Melissa Officinalis Review and Vagostabyl (calcium Lactate, Crataegus Laevigata, Melissa Officinalis Label ), MICARDIS (View Micardis Review and Micardis Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4851105-2 | Abnormal Faeces, Colitis, Constipation, Diarrhoea Haemorrhagic, Flatulence, Large Intestinal Haemorrhage, Petechiae
on Nov 24, 2005 Female patient from FRANCE , 60 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), influenza immunisation and was treated with Furadantin (View Usage). Patient had the following side effects: abnormal faeces, colitis, constipation (What is constipation?), diarrhoea haemorrhagic, flatulence, large intestinal haemorrhage, petechiae. Furadantin dosage: See Image. During the same period patient was treated with VAXIGRIP (INFLUENZA VIRUS VACCINE POLVALENT) SOLUTION (1 Df Once Only, Intramuscular) (View Vaxigrip (influenza Virus Vaccine Polvalent) Solution Review and Vaxigrip (influenza Virus Vaccine Polvalent) Solution Label ).

4832029-3 | Colitis, Large Intestinal Haemorrhage, Rectal Discharge
Patient was taking Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: colitis, large intestinal haemorrhage, rectal discharge on Nov 02, 2005 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), influenza immunisation and. Furadantin dosage: See Image, Oral. During the same period patient was treated with INFLUENZA VACCINE (INFLUENZA VACCINE) SOLUTION (2 Df Three Times Daily, Oral) (View Influenza Vaccine (influenza Vaccine) Solution Review and Influenza Vaccine (influenza Vaccine) Solution Label ).

4804499-8 | Anorexia, Biliary Cyst, Blood Amylase Increased, C-reactive Protein Increased, Cholelithiasis, Cholestasis, Cytolytic Hepatitis, Dizziness, Dyspnoea
Adverse event was reported on Sep 30, 2005 by a Male patient taking Furadantin (View Usage) (Dosage: 1 Df Daily, Oral) was diagnosed with dysuria and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: anorexia, biliary cyst, blood amylase increased, c-reactive protein increased, cholelithiasis, cholestasis, cytolytic hepatitis, dizziness (What is dizziness?), dyspnoea. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREVISCAN (FLUINDIONE) TABLET (View Previscan (fluindione) Tablet Review and Previscan (fluindione) Tablet Label ), LOGIRENE (FUROSEMIDE, AMILORIDE HYDROCHLORIDE) (View Logirene (furosemide, Amiloride Hydrochloride) Review and Logirene (furosemide, Amiloride Hydrochloride) Label ), DOLIPRANE (PARACETAMOL) TABLET (View Doliprane (paracetamol) Tablet Review and Doliprane (paracetamol) Tablet Label ), TRIATEC (RAMIPRIL) CAPSULES (View Triatec (ramipril) Capsules Review and Triatec (ramipril) Capsules Label ), CORDARONE (View Cordarone Review and Cordarone Label ), HEPT A MYL (HEPTAMINOL HYDROCHLORIDE) (View Hept-a-myl (heptaminol Hydrochloride) Review and Hept-a-myl (heptaminol Hydrochloride) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

4796347-X | Diarrhoea, Renal Failure
on Sep 26, 2005 Female patient from FRANCE , child 10 years of age, was diagnosed with cystitis and was treated with Furadantin (View Usage). Patient had the following side effects: diarrhoea, renal failure. Furadantin dosage: 1 Df Three Times Daily, Oral. During the same period patient was treated with FUROSEMIDE (Oral) (View Furosemide Review and Furosemide Label ), VAGOSTABYL (CALCIUM, LACTATE, CRATAEGUS LAEVIGATA, MELISSA OFFICINALIS (View Vagostabyl (calcium, Lactate, Crataegus Laevigata, Melissa Officinalis Review and Vagostabyl (calcium, Lactate, Crataegus Laevigata, Melissa Officinalis Label ), KARDEGIC(ACETYLSALICYLATE LYSINE) (View Kardegic(acetylsalicylate Lysine) Review and Kardegic(acetylsalicylate Lysine) Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

4778599-5 | Asthenia, Myelodysplastic Syndrome, Pancytopenia
on Sep 09, 2005 Male patient from FRANCE , 75 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: asthenia, myelodysplastic syndrome, pancytopenia. Furadantin dosage: Oral. During the same period patient was treated with CIPROFLOXACIN HCL (Oral) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), HEPARIN (View Heparin Review and Heparin Label ), REQUIP (View Requip Review and Requip Label ), MODOPAR (LEVODOPA, BENSERAZIDE HYDROCHLORIDE) (View Modopar (levodopa, Benserazide Hydrochloride) Review and Modopar (levodopa, Benserazide Hydrochloride) Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), PROSCAR (View Proscar Review and Proscar Label ).

4776445-7 | Autoimmune Hepatitis, Bile Duct Stone, Cholangitis, Cytolytic Hepatitis, Hepatic Fibrosis, Hepatic Pain, Hepatomegaly, Jaundice, Nausea
Patient was taking Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune hepatitis, bile duct stone, cholangitis, cytolytic hepatitis, hepatic fibrosis, hepatic pain, hepatomegaly, jaundice (What is jaundice?), nausea (What is nausea?) on Sep 01, 2005 from FRANCE Additional patient health information: Female patient , 59 years of age, . Furadantin dosage: See Image. Patient was hospitalized.

4765775-0 | Chest Pain, Chest X-ray Abnormal, Dyspnoea, Fatigue, Interstitial Lung Disease, Pleural Fibrosis, Pulmonary Fibrosis, Renal Impairment, Respiratory Failure
Adverse event was reported on Aug 24, 2005 by a Female patient taking Furadantin (View Usage) (Dosage: 50 Mg, Every 2day, Oral) was diagnosed with urinary tract disorder, rheumatoid arthritis (What is rheumatoid arthritis?), essential hypertension and. Location: AUSTRALIA , 84 years of age, Patient had the following side effects: chest pain (What is chest pain?), chest x-ray abnormal, dyspnoea, fatigue, interstitial lung disease, pleural fibrosis, pulmonary fibrosis (What is pulmonary fibrosis?), renal impairment, respiratory failure. During the same period patient was treated with INDAPAMIDE (2.5 Mg Daily) (View Indapamide Review and Indapamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (0.5 Mg, Daily) (View Folic Acid Review and Folic Acid Label ), PERINDOPRIL (PERINDOPRIL) (4 Mg Daily) (View Perindopril (perindopril) Review and Perindopril (perindopril) Label ), NAPROSYN (750 Mg Daily) (View Naprosyn Review and Naprosyn Label ), PRO BANTHINE (PROPANTHELINE BROMIDE) (View Pro-banthine (propantheline Bromide) Review and Pro-banthine (propantheline Bromide) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), RANIDITINE (RANITIDINE) (View Raniditine (ranitidine) Review and Raniditine (ranitidine) Label ). Patient was hospitalized.

4691090-X | Hypotension, Urticaria
on May 26, 2005 Female patient from , 58 years of age, was diagnosed with cystitis and was treated with Furadantin (View Usage). After Furadantin was administered, patient had the following side effects: hypotension, urticaria. Furadantin dosage: 1 Unit, Oral. Patient was hospitalized.

4681941-7 | Blood Urine Present, Condition Aggravated, International Normalised Ratio Increased
on May 18, 2005 Female patient from , 75 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), atrial fibrillation (What is atrial fibrillation?) and was treated with Furadantin (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, condition aggravated, international normalised ratio increased. Furadantin dosage: Oral. During the same period patient was treated with PREVISCAN (FLUINDIONE) (Oral (see Image)) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), LERCAN (LERCANIDIPINE HYDROCHLORIDE) (View Lercan (lercanidipine Hydrochloride) Review and Lercan (lercanidipine Hydrochloride) Label ).

4559444-X | Henoch-schonlein Purpura, Petechiae, Platelet Count Decreased
Patient was taking Furadantin (View Usage). Patient had the following side effects: henoch-schonlein purpura, petechiae, platelet count decreased on Jan 12, 2005 from Additional patient health information: Female patient , 78 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Furadantin dosage: 50 Mg Three Times Daily, Oral; 50 Mg Three Times Daily, Unk. During the same period patient was treated with VASTAREL (TRIMETAZIDINE HYDROCHLORIDE) (View Vastarel (trimetazidine Hydrochloride) Review and Vastarel (trimetazidine Hydrochloride) Label ), NATISPRAY (GLYCERYL TRINITRATE) (View Natispray (glyceryl Trinitrate) Review and Natispray (glyceryl Trinitrate) Label ), APROVEL (IRBESARTAN) (View Aprovel (irbesartan) Review and Aprovel (irbesartan) Label ), INFLUENZA VACCINE (INFLUENZA VACCINE) (View Influenza Vaccine (influenza Vaccine) Review and Influenza Vaccine (influenza Vaccine) Label ). Patient was hospitalized.